MannKind Announces FDA Approval of Furoscix ReadyFlow(TM), the First and Only Autoinjector Delivering IV-Equivalent Diuretic Therapy for the Treatment of Edema in Adults with Heart Failure or Chronic Kidney Disease
July 24, 2026
Best Biotech Penny Stocks in June 2021? Check These 4 Out
May 26, 2021
Related Post
-
-
BiomX Subsidiary Zorronet Expands European Presence Through Two Strategic Collaborations in Europe
July 24, 2026
-
Evogene Ltd. and ELEO Inc. Announce Collaboration to Develop Next-Generation Oral Small-Molecule PCSK9 Pathway Inhibitors for Hyperlipidemia and Cardiovascular Diseases
July 22, 2026
-
Akari Therapeutics Enters Strategic Research Collaboration with Whitehawk Therapeutics
July 21, 2026